To evaluate whether the scFvB1IL15 immunocytokine was also able to specifically stimulate NK cells in the PBMCs isolated from the CLL patients and restore the observed functional gaps, we first performed the cytotoxic assay as previously described for the samples from the HDs by using the equimolar concentration of IL15. Here, IL15 is linked to B-cell chronic lymphocytic leukemia.